Lucyd, Inc
Lucyd, Inc
- Market cap
- $296.10K
Your view on LUCYW
Overview
What the company does, where it operates, and who runs it.
About Lucyd, Inc
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Harrison Reed Gross
- Headquarters
- 11900 Biscayne Blvd., North Miami, FL, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Harrison Reed Gross
- Headquarters
- 11900 Biscayne Blvd., North Miami, FL, US
Lucyd, Inc develops and sells smart eyewear in North America.
It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025.
Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Lucyd, Inc. Starting points for Lucyd, Inc: EPS -$0.97, beta 2.65 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Lucyd, Inc. Trailing twelve-month EPS for Lucyd, Inc stands at -$0.97. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|
| Average estimate | −$0.13 | −$1.23 | −$0.42 |
| Lowest estimate | −$0.13 | −$1.23 | −$0.42 |
| Highest estimate | −$0.13 | −$1.23 | −$0.42 |
| Number of analysts | 1 | 1 | 1 |
| A year ago | −$0.141 | −$1.901 | — |
| Growth vs a year ago | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|
| Average estimate | $3.50M | $7.20M | $22.00M |
| Lowest estimate | $3.50M | $7.20M | $22.00M |
| Highest estimate | $3.50M | $7.20M | $22.00M |
| Number of analysts | 1 | 1 | 1 |
| A year ago | $959810.00 | $2.66M | — |
| Growth vs a year ago | +264.7% | +170.5% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Lucyd, Inc. Lucyd, Inc has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| BIAFWbioAffinity Technologies, Inc. | Healthcare | Medical - Diagnostics & Research | $5.5M | ||
| CEOSPsykey, Inc. | Healthcare | Medical - Instruments & Supplies | $33,018 | ||
| FEMYFemasys Inc. | Healthcare | Medical - Instruments & Supplies | $10.7M | ||
| GMVDFG Medical Innovations Holdings Ltd | Healthcare | Medical - Devices | $25,992 | ||
| LUCYInnovative Eyewear, Inc. | Healthcare | Medical - Instruments & Supplies | $6.1M | ||
| SDCCQSmileDirectClub, Inc. | Healthcare | Medical - Specialties | $13,395 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| STVNStevanato Group S.p.A. | Healthcare | NYSE | $4.3B | ||
| STXSStereotaxis, Inc. | Healthcare | AMEX | $95.0M | ||
| SUVPFSartorius AG | Healthcare | OTC | $18.7B | ||
| SVSOSheerVision, Inc. | Healthcare | OTC | $2,551 | ||
| TCGGYTecan Group AG | Healthcare | OTC | $2.3B | ||
| TCHBFTecan Group AG | Healthcare | OTC | $2.2B | ||
| TDVXFTobii Dynavox AB (publ) | Healthcare | OTC | $981.6M | ||
| TFXTeleflex Incorporated | Healthcare | NYSE | $6.4B | ||
| TGLVYTop Glove Corporation Bhd. | Healthcare | OTC | $1.1B | ||
| TRJ.AXTrajan Group Holdings Limited | Healthcare | ASX | — | ||
| TRUMFTerumo Corporation | Healthcare | OTC | $18.9B | ||
| TRUMYTerumo Corporation | Healthcare | OTC | $19.5B | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Lucyd, Inc executives and directors. Shares of Lucyd, Inc have traded between $0.02 and $0.49 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Lucyd, Inc. Coverage tracks Lucyd, Inc within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Lucyd, Inc.